Sangamo Therapeutics Inc. (SGMO)

8.79
NASDAQ : Health Technology
Prev Close 9.00
Day Low/High 8.77 / 9.12
52 Wk Low/High 6.26 / 27.50
Avg Volume 1.90M
Exchange NASDAQ
Shares Outstanding 102.09M
Market Cap 918.84M
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)
Today's Weak On High Volume Stock: Sangamo BioSciences (SGMO)

Today's Weak On High Volume Stock: Sangamo BioSciences (SGMO)

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a weak on high relative volume candidate

Commit To Buy Sangamo BioSciences At $5, Earn 23% Using Options

Commit To Buy Sangamo BioSciences At $5, Earn 23% Using Options

Investors considering a purchase of Sangamo BioSciences Inc shares, but tentative about paying the going market price of $6.91/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2018 put at the $5 strike, which has a bid at the time of this writing of $1.15.

These 5 Biotech Stocks Under $10 Are About to Break Out

These 5 Biotech Stocks Under $10 Are About to Break Out

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

7 Stocks Under $10 to Trade for Breakout Gains

7 Stocks Under $10 to Trade for Breakout Gains

These stocks trading for less than $10 a share are within range of triggering big breakout trades.

Sangamo BioSciences (SGMO) Flagged As Strong On High Volume

Sangamo BioSciences (SGMO) Flagged As Strong On High Volume

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a strong on high relative volume candidate

Sangamo BioSciences Becomes Oversold (SGMO)

Sangamo BioSciences Becomes Oversold (SGMO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Strong On High Volume: Sangamo BioSciences (SGMO)

Strong On High Volume: Sangamo BioSciences (SGMO)

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a strong on high relative volume candidate

Oversold Conditions For Sangamo BioSciences (SGMO)

Oversold Conditions For Sangamo BioSciences (SGMO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Sangamo BioSciences (SGMO) Is Strong On High Volume Today

Sangamo BioSciences (SGMO) Is Strong On High Volume Today

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a strong on high relative volume candidate

Trade-Ideas: Sangamo BioSciences (SGMO) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: Sangamo BioSciences (SGMO) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a strong on high relative volume candidate

Sangamo BioSciences (SGMO) Flagged As Strong On High Volume

Sangamo BioSciences (SGMO) Flagged As Strong On High Volume

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a strong on high relative volume candidate

Sangamo BioSciences Stock Sees Short Interest Increase 16%

Sangamo BioSciences Stock Sees Short Interest Increase 16%

The most recent short interest data has been released by the NASDAQ for the 09/30/2015 settlement date, which shows a 1,736,801 share increase in total short interest for Sangamo BioSciences Inc , to 12,619,596, an increase of 15.96% since 09/15/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Interesting SGMO Put And Call Options For January 2018

Interesting SGMO Put And Call Options For January 2018

Investors in Sangamo BioSciences Inc saw new options begin trading today, for the January 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 830 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector

Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector

The shares of Spark Therapeutics are surging after the company announced that its lead gene therapy product candidate had met its primary endpoint in a Phase 3 trial.

Trade-Ideas: Sangamo BioSciences (SGMO) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: Sangamo BioSciences (SGMO) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a weak on high relative volume candidate

Sangamo BioSciences Enters Oversold Territory (SGMO)

Sangamo BioSciences Enters Oversold Territory (SGMO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Today's Weak On High Volume Stock: Sangamo BioSciences (SGMO)

Today's Weak On High Volume Stock: Sangamo BioSciences (SGMO)

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a weak on high relative volume candidate

Sangamo BioSciences (SGMO) Showing Signs Of Perilous Reversal Today

Sangamo BioSciences (SGMO) Showing Signs Of Perilous Reversal Today

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a "perilous reversal" (up big yesterday but down big today) candidate

Oversold Conditions For Sangamo BioSciences (SGMO)

Oversold Conditions For Sangamo BioSciences (SGMO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Stocks Ready for Breakouts

5 Stocks Ready for Breakouts

These stocks look poised to break out and trade higher from current levels.

Sangamo BioSciences (SGMO) Highlighted As Weak On High Volume

Sangamo BioSciences (SGMO) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a weak on high relative volume candidate

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABC, CAM, CLFD, DGII, GIMO, HMTV, ISRG, MNST, MYE Downgrades: ASNA, BCC, BMY, CENX, CRAI, CYBE, EEP, ELSE, ICON, MFSF, MICT, PDS, QLGC, SEAC, SGMA, SGMO, TK Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Sangamo BioSciences (SGMO) Is Today's Strong On High Volume Stock

Sangamo BioSciences (SGMO) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a strong on high relative volume candidate

Sangamo BioSciences Becomes Oversold (SGMO)

Sangamo BioSciences Becomes Oversold (SGMO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting SGMO Put And Call Options For February 2016

Interesting SGMO Put And Call Options For February 2016

Investors in Sangamo BioSciences Inc saw new options begin trading this week, for the February 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Sangamo BioSciences (SGMO) Stock: Weak On High Volume Today

Sangamo BioSciences (SGMO) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a weak on high relative volume candidate

Sangamo BioSciences (SGMO) Highlighted As Weak On High Volume

Sangamo BioSciences (SGMO) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a weak on high relative volume candidate

MKM Partners' 4 Health Care Stocks to Sell Before June

MKM Partners' 4 Health Care Stocks to Sell Before June

June has historically been one of the weakest months for equities, which means stock selection -- both buying and selling -- will be critical over the short term.

Today's Weak On High Volume Stock: Sangamo BioSciences (SGMO)

Today's Weak On High Volume Stock: Sangamo BioSciences (SGMO)

Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a weak on high relative volume candidate

Sangamo BioSciences Becomes Oversold (SGMO)

Sangamo BioSciences Becomes Oversold (SGMO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

TheStreet Quant Rating: D+ (Sell)